Developed in partnership with the Johns Hopkins Applied Physics Laboratory (APL), the module is built around a multi-segment RT-PCR method with integrated indexing
Consolidated revenue from operations stood at Rs. 111.05 crore
FDA closes inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad with 2 observations
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
OERIS offers extended antiemetic coverage through a single injection that effectively prevents both acute and delayed CINV for up to five days
Tinostamustine is an investigational drug with a potential first-in-class mechanism combining bifunctional alkylating activity and pan histone deacetylase (HDAC) inhibition
The partnership aligns with the launch of Oracle Health’s next-generation electronic health record
Syngene International has reported total income of Rs. 926 crore during the period ended September 30, 2025
Subscribe To Our Newsletter & Stay Updated